All News

26/02 Spectral Medical Provides Update on PMA Submission MT
26/02 Spectral Medical Inc. Provides Update on PMA Submission Timing for PMX-20R CI
26/02 Spectral Medical Provides Update on PMA Submission Timing for PMX-20R AQ
10/12 Spectral Medical Inc. - Special Call
07/11 Spectral Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
07/11 Spectral Medical Provides Update on PMX Submission to FDA, Also Reports Q3 Loss MT
07/11 Spectral Medical Brief: Says PMA Submission Targeted for Q1 2026 Following "Positive" Tigris results and ongoing FDA interactions MT
07/11 Spectral Medical Brief: Total Q3 Revenue Increased to $675,000 compared to $502,000 for the same period in 2024 MT
07/11 Spectral Medical Q3 revenue up 34% RE
07/11 Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update AQ
29/25/29 Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF AQ
16/25/16 Spectral Medical Provides Observational Study Update MT
16/25/16 Spectral Medical Inc. Announces Publication of Eden Observational Study CI
16/25/16 Spectral Medical Announces Publication of EDEN Observational Study AQ
08/25/08 Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 – 9, 2025 AQ
25/25/25 Spectral Medical Receives US$3 Million From Vantive MT
25/25/25 Spectral Medical receives US$3 million from Vantive RE
25/25/25 Spectral Medical Brief: Says Received US$3 Million From Vantive MT
25/25/25 Spectral Medical Receives US$3 Million From Vantive AQ
25/25/25 Spectral Medical Inc. announced that it has received $10 million in funding CI
14/25/14 Spectral Medical Inc. - Special Call
13/25/13 Canadian Investment Regulatory Organization Trade Resumption - EDT AQ
13/25/13 Spectral Medical and Vantive Release Topline Results From Phase 3 Endotoxic Septic Shock Study MT
13/25/13 Canadian Investment Regulatory Organization Trading Halt - EDT AQ
13/25/13 Spectral Medical and Vantive Announce Topline Results from Spectral’s Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock AQ
No results for this search
  1. Stock Market
  2. Equities
  3. EDT Stock
  4. News Spectral Medical Inc.
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW